🔗 Share this article

An underground economy for unapproved weight-loss medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are encouraged to message these accounts directly for supplier links, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a flourishing market exists on Telegram, where communities with thousands of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Professionals Voice Concerns

Nevertheless, physicians and chemists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals injecting products of unknown origin.

Some experts said the popularity for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach pharmaceutical, advertising, and customer laws, risking fines, prosecution or imprisonment.

Service Reaction and Material Removal

According to the social media company, the service has removed problematic content and prohibited related keywords and query recommendations. The organization said it was committed to maintaining the platform secure and investing in enhancing compliance measures.

Digital Trading Activities

Research also found groups with up to nine thousand members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up groups with thousands of members, populated with photos of weight loss, positive testimonials and detailed guides for mixing or administering at residence.

Within minutes of joining one community, a seller shared contact information, where most purchases take place. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, health issues or previous experience.

Product Details and Pricing

Within these communities, posts display dark colored packages with postal service stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20 milligrams. When questioned how much time a injector should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for Telegram stated it actively moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering materials they can’t verify. Even if the science behind retatrutide is valid, these online products may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.

Her staff has already encountered individuals harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject patients to possibly serious medical dangers”.